Risk-factor profile in severe, generalized, obliterating vascular disease.
A 74-year-old woman had a history over 25 years of endarterectomy of both renal arteries, iliac venous thrombosis, pulmonary embolism, left internal carotid artery endarterectomy, coronary angioplasty, aortocoronary bypass grafting, occlusion of the right axillary artery, lower-limb claudication due to common iliac artery aneurysm, external iliac artery stenosis, multiple femoral artery stenoses, bifurcational stent grafting, occlusion of the left brachial artery and the right external iliac artery, and stroke. Assessment of the risk-factor profile revealed an absence of classic risk factors but the presence of the factor V Leiden mutation, the methylenetetrahydrofolate reductase AI298C mutation, the HFE C282Y mutation, plasminogen activator inhibitor-1 gene mutation, the -455 G/A fibrinogen gene polymorphism, the epsilon3/epsilon4 apolipoprotein E -675 4G gene polymorphism, and hyperhomocysteinemia. This case shows that severe, generalized, occlusive vascular disease may be due to the combination of various genetic risk factors for atherosclerosis and venous thromboembolism.
Finsterer
Josef
J
Department of Neurology, Krankenanstalt Rudolfstiftung, Vienna, Austria. duarte@aonmail.at
Dossenbach-Glaninger
Astrid
A
Krugluger
Walter
W
Stöllberger
Claudia
C
Hopmeier
Piere
P
D000368:Aged; D001057:Apolipoproteins E / Q000235:genetics; D001162:Arteriosclerosis Obliterans / Q000150:complications / Q000235:genetics*; D005165:Factor V / Q000235:genetics; D005260:Female; D005340:Fibrinogen / Q000235:genetics; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D020138:Hyperhomocysteinemia / Q000175:diagnosis; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics; D009154:Mutation; D011110:Polymorphism, Genetic; D012307:Risk Factors
D001057:Apolipoproteins E; C095381:factor V Leiden; D005165:Factor V; D005340:Fibrinogen; D042965:Methylenetetrahydrofolate Reductase (NADPH2)